Srs Capital Advisors, Inc. Astrazeneca PLC Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 4,210 shares of AZN stock, worth $313,897. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,210
Previous 3,227
30.46%
Holding current value
$313,897
Previous $251,000
9.56%
% of portfolio
0.02%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding AZN
# of Institutions
1,355Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.5 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.06 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.8 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.79 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...